Human immunodeficiency virus (HIV) causing Acquired immunodeficiency syndrome (AIDS) is a major public health problem [1]. The rapid extension of HIV is a global health challenge that has both social and economic implications [2]. Currently there are 40 million individuals infected with the HIV globally [3]. Nearly 95% of the infected ones are unaware of their HIV or AIDS status [4]. Central Asia is a region of concern for expanding HIV epidemics [5]. South Asia is currently home to >2.5 million HIV infected individuals [6]. Such an enormous number of people with the infection necessitate proper address. The Journal of HIV for Clinical and Scientific Research, being operated from India, is an attempt to report updates of researches across the world to this part of the earth and vice versa.

Entering medical care soon after diagnosis is essential if people living with HIV are to benefit from life prolonging HIV care [7]. Voluntary counseling and testing has been an important tool employed by World Health Organization (WHO) and other health organizations worldwide to identify new cases and implement treatment as prevention strategies [8]. Further, WHO estimates that nearly 16,000 new infections occur worldwide daily [3]. Round the globe, approximately 4000 people die each day with HIV/AIDS. It is a major health problem, mainly for the developing world [4].

With this information in background, the journal aims at publishing research papers on different facets of HIV like epidemiology, pathophysiology, early detection, monitoring, anti-retroviral therapy, adherence and palliative care. Further, opportunistic infections and concomitant infections such as hepatitis C in HIV/AIDS are also part of the journal. Viral genetic variability and link to neurological outcomes like cognitive disorders; neurological imaging in HIV infection; and impact of HIV treatments on neurological behavioral functions are other prime areas of expertise. Apart from these, the journal has a vision on promoting the overall aspects of recent advances and updates on virology; immunology and biomarkers; and development of new drugs and vaccine. Besides, papers on substance abuse, prevention, patient education, health literacy programs, political and economical aspects of HIV are given due priority.

It is an open access journal with all contents freely available to medical community throughout the world. The team of the journal consists of experts of related scientific publications worldwide. All the submitted papers undergo various phases to ensure publication quality. The manuscripts are put through the standard peer review process. Once submitted, there is initial screening by the editors. Suitable papers then will be sent to at least two independent referees. The reports from the referees are then considered by the Editor-in-Chief, who will make the final decision. We always aim at providing quick and quality feedback to our valued authors so that their work can be made available to global society timely. Peertechz.com is a non-profit organization determined to expand medical knowledge worldwide free of cost. Hence, we need to levy article processing charges for the contributors which are the flat charges with no additional charging of whatsoever nature. These are the only source of funding for the journal that covers the publishing, maintaining and archiving of the journal contents.

We invite the international scientific community working in the field of HIV/AIDS to come forward and join our initiative. It is high time; we make all the concerned authorities working in field of HIV/AIDS aware about the updates of the disease through scientific studies in various parts of the world so that all the infected ones get timely proper care. The Journal of HIV for Clinical and Scientific Research, through this inaugural issue, invites all the scientists working in the disease vicinity to submit their valued works so that we can put it at the reach of all concerned audience.